AI Summary Neoral and Gengraf (cyclosporine modified) are calcineurin inhibitors taken in two daily doses to help prevent organ rejection after liver transplantation.
Medically reviewed.
Neoral and Gengraf (cyclosporine modified) are prescription immunosuppressant medications used to prevent organ rejection after liver transplantation. They belong to a class of medications called calcineurin inhibitors and help suppress immune responses that could damage the transplanted liver. Both are modified microemulsion formulations designed to provide more consistent absorption than older cyclosporine formulations. Treatment decisions should always be individualized and guided by your transplant healthcare team.
This page covers the role of Neoral and Gengraf after liver transplant — how they work, who may be prescribed them, how they are used, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance.
Neoral and Gengraf are modified forms of cyclosporine. Learn about the original formulation on the Sandimmune page.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT NEORAL / GENGRAF TREATMENT
Neoral and Gengraf are prescription medicines that contain cyclosporine modified. They are immunosuppressants used to prevent organ rejection after liver transplantation. Both belong to a class of medications called calcineurin inhibitors.
Neoral and Gengraf are modified microemulsion formulations. They are designed to provide more consistent absorption than older cyclosporine formulations. They are available as modified capsules and as an oral solution. The original cyclosporine formulation is covered on the Sandimmune page.
Neoral and Gengraf are used as part of an individualized post-transplant plan. Your transplant team monitors you regularly, including with blood tests such as Liver Function Tests (LFTs).
WHO NEORAL / GENGRAF MAY BE PRESCRIBED FOR
Your healthcare provider may prescribe Neoral or Gengraf if you have received a liver transplant and need long-term immunosuppressive therapy. It may also be chosen when you need prevention of acute or chronic rejection, or when a modified cyclosporine formulation with more predictable absorption suits your plan.
The decision depends on your transplant status, your overall health, and your treatment goals. Your healthcare provider must determine that cyclosporine is appropriate for your treatment plan.
Because every patient's health profile is different, there is no one-size-fits-all answer. Treatment decisions should be made by your transplant healthcare team after a full assessment.
ELIGIBILITY OVERVIEW
Neoral or Gengraf may be considered for adults with the following conditions or treatment goals:
Before and during treatment, your transplant team reviews several factors to decide whether cyclosporine remains appropriate, including:
HOW NEORAL / GENGRAF PROTECT YOUR NEW LIVER
After a liver transplant, your immune system can see the new liver as foreign and attack it. This is called rejection. Neoral and Gengraf suppress T-cell activation, which is the immune step involved in organ rejection.
By calming this response, they reduce immune-mediated damage to the transplanted liver. They help prevent acute rejection episodes, support long-term graft survival (how long the transplanted liver keeps working), and help maintain stable transplant function.
Neoral and Gengraf are not used on their own without follow-up. Your transplant team pairs them with regular monitoring of cyclosporine levels, kidney function, liver function, blood pressure, and lipid levels.
TRANSPLANT BENEFITS
Rejection happens when your immune system treats the new liver as foreign. Neoral and Gengraf suppress T-cell activation, the immune step involved in this response. This helps prevent acute rejection episodes, and these medicines are also used to prevent chronic rejection.
By calming immune activity that could harm the organ, Neoral and Gengraf reduce immune-mediated damage to the transplanted liver. This protection matters in the first weeks after surgery and in the years that follow.
Graft survival is how long the transplanted liver keeps working. Long-term immunosuppression supports graft survival, which is why these medicines are generally continued as maintenance therapy unless your healthcare provider changes your plan.
Stable transplant function means your new liver keeps doing its job day to day. By limiting immune attack on the organ, Neoral and Gengraf help maintain that stability. Your transplant team checks liver function, kidney function, and cyclosporine levels regularly to see how your liver is doing.
Neoral and Gengraf work by calming the immune response that causes rejection. They should only be started, adjusted, and monitored by your transplant healthcare team.
TREATMENT PROCESS
Neoral and Gengraf come as modified capsules and as an oral solution. Take them exactly as prescribed, and ask your pharmacist if you have questions about your form or strength.
Typical starting doses are 5-10 mg/kg/day, divided into two daily doses. Your transplant team determines the right dose for you.
Take Neoral or Gengraf at the same times each day, without missing doses. Avoid grapefruit products, including grapefruit juice, unless your healthcare provider approves them.
Neoral and Gengraf are generally used as long-term or lifelong maintenance immunosuppressive therapy following liver transplantation unless your healthcare provider modifies your treatment regimen. Doses are often gradually reduced after transplantation to the lowest effective maintenance dose while maintaining adequate protection against rejection.
Store Neoral and Gengraf at room temperature, away from moisture and heat.
Regular monitoring of cyclosporine levels, kidney function, liver function, blood pressure, and lipid levels is required. Attend all scheduled laboratory tests and transplant follow-up visits, and report any side effects or unusual symptoms to your team.
BENEFITS AND SAFETY
Neoral and Gengraf help protect the transplanted liver by preventing rejection. Long-term immunosuppression supports graft survival, and the modified formulation gives more consistent absorption than older cyclosporine. They are an established post-transplant therapy.
As with any medication, Neoral and Gengraf can cause side effects. Common ones include changes in kidney function, high blood pressure, tremor, gum overgrowth, and increased hair growth. Your transplant team monitors cyclosporine levels, kidney function, blood pressure, and lipid levels throughout treatment, and adjusts your plan as needed to balance benefits and risks.
BENEFITS
Neoral and Gengraf are modified microemulsion formulations. They are designed to give more consistent absorption than older cyclosporine formulations, which means the amount of medicine reaching your bloodstream is more predictable from dose to dose.
Your starting dose is split into two daily doses. Over time, your transplant team individualizes your maintenance dose based on your cyclosporine blood levels, transplant status, kidney function, and clinical response. Doses are often reduced gradually to the lowest effective maintenance dose.
Neoral and Gengraf are available as modified capsules and as an oral solution. Your healthcare provider can discuss which form fits your treatment plan.
Neoral and Gengraf are an established therapy after liver transplantation. Transplant teams use them as part of long-term care, along with regular monitoring of your blood levels, kidney function, liver function, blood pressure, and lipid levels.
Your transplant team will discuss the potential benefits and risks before treatment. They provide ongoing support, including regular checks of cyclosporine levels, kidney function, and blood pressure, to help ensure safe use. Report any new or unusual symptoms promptly.
SUPPORTING YOUR RESULTS
Daily habits are an important part of your care alongside Neoral or Gengraf. Taking your medicine consistently, protecting yourself from infection, and keeping up with monitoring all help your transplant team keep your treatment safe and effective.
These habits can support how your body responds to treatment and help protect your transplanted liver over time.
Daily habits that may support treatment:
Common Questions
Neoral / Gengraf (Cyclosporine) is used to help prevent organ rejection after liver transplantation. It is a calcineurin inhibitor, a type of immunosuppressant. It suppresses T-cell activation, the immune step involved in rejection, which reduces immune damage to the transplanted liver and supports long-term graft survival. It is an established post-transplant therapy. Your transplant healthcare team decides whether it fits your treatment plan, so talk with them about your goals and questions.
Neoral or Gengraf may be prescribed if you have received a liver transplant and need long-term immunosuppressive therapy. It may be chosen to prevent acute or chronic rejection, or when you need a modified cyclosporine formulation with more predictable absorption. Your healthcare provider must decide that cyclosporine is appropriate for you, based on your transplant status, overall health, and treatment goals. Ask your transplant team whether it suits your situation.
Neoral and Gengraf are modified microemulsion formulations designed to provide more consistent absorption than older cyclosporine formulations. Sandimmune is the original cyclosporine formulation and has different absorption characteristics than modified products. All of them are prescription immunosuppressants used after liver transplantation. Your healthcare provider chooses the product that fits your plan, so ask your transplant team why they recommend a particular one.
Neoral and Gengraf are generally used as long-term or lifelong maintenance therapy after liver transplant, unless your healthcare provider changes your regimen. Doses are often reduced gradually after transplant to the lowest effective maintenance dose that still protects you against rejection. Do not stop taking it or change your dose on your own. Talk with your transplant team about what your long-term plan looks like.
Common side effects include changes in kidney function, high blood pressure, tremor, gum overgrowth, and increased hair growth. Because of these risks, regular monitoring of cyclosporine levels, kidney function, liver function, blood pressure, and lipid levels is required. Attend all scheduled lab tests and follow-up visits, and report new or unusual symptoms promptly. Your transplant team can explain how the benefits and risks apply to you.
Avoid grapefruit and grapefruit juice while taking Neoral or Gengraf unless your healthcare provider approves them. Check with your transplant healthcare team before starting any new medication or supplement. Take your dose at the same times each day and do not miss doses. Your team can give you personalized guidance on food, medicines, and daily habits that support your treatment.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
